Ascendiant Capital Reiterates Buy Rating on DUOT
Ascendiant Capital has reiterated its buy rating on DUOT, setting a price target of $22.
Key Points
- Ascendiant Capital reiterated its buy rating on DUOT with a price target of $22 on June 15, 2026.
- DUOT shares are trading at $11.68, with active institutional interest from firms like Alyeska Investment Group.
- Insider and institutional activities reflect ongoing interest, with recent insider purchases and analyst targets indicating potential growth.
Ascendiant Capital has reiterated its buy rating on DUOT, setting a price target of $22. This update was issued on June 15, 2026, as analyst Edward Woo continues to express confidence in the company's potential.
Other Institutional Activity in DUOT
Several institutional investors have shown interest in DUOT. Alyeska Investment Group added 1,906,659 shares, now holding the same amount valued at approximately $13.08 million. Bleichroeder LP maintained its position with 1,627,806 shares valued at about $11.17 million. Royal Bank of Canada increased its stake by 365,324 shares, reaching a total of 1,330,691 shares worth $9.13 million. Northern Right Capital Management added 300,000 shares, bringing its total to 1,077,626 shares valued at $7.39 million. Morgan Stanley also increased its holdings by 254,177 shares, now owning 1,061,729 shares valued at $7.28 million.
DUOT Stock Snapshot
Shares of DUOT are currently trading at $11.68. Institutional interest and analyst confidence suggest potential growth, with the stock's activity reflecting a dynamic investment landscape.
Insider Buying and Selling at Duos Technologies Group, Inc.
Recent insider activity includes several purchases on March 31, 2026. Ned Mavrommatis bought 2,988 shares at $6.69 each. Brian James, James Craig Nixon, and Frank Lonegro each acquired 3,735 shares at the same price. Earlier, on December 31, 2025, Frank Lonegro purchased 12,185 shares at $11.44.
Analysts Set New Price Targets
On June 15, 2026, Ascendiant Capital maintained its buy rating on DUOT with a price target of $22. The firm has consistently expressed confidence, previously setting targets of $17 on April 17, 2026, and $14 on December 30, 2025. The consensus among analysts is a buy recommendation, with a mean target price reflecting optimism about DUOT's future.
Bottom Line
Ascendiant Capital's reiterated buy rating and increased price target highlight continued confidence in DUOT's prospects. Institutional interest and insider transactions further suggest that the company is on investors' radars. As always, it's important to remember that these insights are based on past filings and analyses, and may not reflect current market conditions.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.